Co-funding Institute(s):
National Heart, Lung, and Blood Institute (NHLBI)
Clinical Research Priorities for Thalassemia
May 20, 2009 - May 21, 2009
Bethesda, MD, United States
Contact for additional information: Dr. Harvey Luksenburg, NICHD 301-451-6766
DescriptionThe goal of this meeting is to allow interested individuals to express their opinions about the directions clinical research in thalassemia should take, given past experiences and limitations imposed by NIH budgets and regulatory requirements. These proceedings will also serve as the basis of a Request for Applications (RFA) for clinical trials in thalassemia.The goal is to allow interested individuals to express their opinions about the directions clinical research in thalassemia should take, given past experiences and limitations imposed by NIH budgets and regulatory requirements.These proceedings will also serve as the basis of a Request for Applications (RFA) for clinical trials in thalassemia.